Roche Anti-Titet - The Cancer Drug That Targets a Protein

The roch anti tiget grug, when combined with their pety one inhibitor call tecentric, that combination did not slow the growth of tumors any faster than just centric alone. The survival data are what the company said was immature, which basically means that they have not been able to collect enough events, i e, patient deaths for a decision about whether or not this tigid compound will prolong the survival patiente. That story is a reminder that one of the other undercurrents of the last decade plus of biotecen and biological history is that munology is very complicated. Watch the hype of and watch the downfall of a handful of these acronymical targets.